migalastat has been researched along with g(m2) ganglioside in 3 studies
Studies (migalastat) | Trials (migalastat) | Recent Studies (post-2010) (migalastat) | Studies (g(m2) ganglioside) | Trials (g(m2) ganglioside) | Recent Studies (post-2010) (g(m2) ganglioside) |
---|---|---|---|---|---|
143 | 14 | 89 | 743 | 13 | 109 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baek, RC; Kasperzyk, JL; Platt, FM; Seyfried, TN | 1 |
Baek, RC; Bronson, RT; Butters, TD; Denny, CA; Heinecke, KA; Kim, YP; Loh, KS; Platt, FM; Seyfried, TN | 1 |
Arthur, JR; Lee, JP; Seyfried, TN; Snyder, EY | 1 |
3 other study(ies) available for migalastat and g(m2) ganglioside
Article | Year |
---|---|
N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
Topics: 1-Deoxynojirimycin; Animals; Animals, Newborn; beta-Hexosaminidase alpha Chain; Brain; Brain Chemistry; Disease Models, Animal; Down-Regulation; G(M2) Ganglioside; Gangliosides; Glycosphingolipids; Mice; Mice, Knockout; Nerve Degeneration; Neuraminidase; Sandhoff Disease; Treatment Outcome | 2008 |
Restricted ketogenic diet enhances the therapeutic action of N-butyldeoxynojirimycin towards brain GM2 accumulation in adult Sandhoff disease mice.
Topics: 1-Deoxynojirimycin; 3-Hydroxybutyric Acid; Analysis of Variance; Animals; beta-N-Acetylhexosaminidases; Blood Glucose; Body Weight; Brain; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Diet, Ketogenic; Eating; G(M2) Ganglioside; Lipid Metabolism; Mice; Mice, Knockout; Myelin Sheath; Purkinje Cells; Sandhoff Disease | 2010 |
Therapeutic effects of stem cells and substrate reduction in juvenile Sandhoff mice.
Topics: 1-Deoxynojirimycin; Animals; beta-N-Acetylhexosaminidases; G(M2) Ganglioside; Hexosaminidase B; Mice; Neural Stem Cells; Sandhoff Disease | 2012 |